TNF and inflammatory bowel disease: Current clinically prescribed IBD drugs such as sulfasalazine, corticosteroids and immunosuppressants focus on targeting the inhibition of the chemokine tumor necrosis factor (TNF) (Moura et al., 2015) and its associated downstream inflammatory response.